Related references
Note: Only part of the references are listed.Trends in clinical development for PD-1/PD-L1 inhibitors
Jia Xin Yu et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Circular RNA hsa_circ_0061825 (circ-TFF1) contributes to breast cancer progression through targeting miR-326/TFF1 signalling
Gaofeng Pan et al.
CELL PROLIFERATION (2020)
Breast cancer stem cell antigens as targets for immunotherapy
Elena Quaglino et al.
SEMINARS IN IMMUNOLOGY (2020)
Targeting LA7 breast cancer stem cells of rat through repressing the genes of stemness-related transcription factors using three different biological fluids
Roghayeh Pourbagher et al.
GENE (2020)
CircRNA_103809 Suppresses the Proliferation and Metastasis of Breast Cancer Cells by Sponging MicroRNA-532-3p (miR-532-3p)
Minfeng Liu et al.
FRONTIERS IN GENETICS (2020)
The Missing Lnc: The Potential of Targeting Triple-Negative Breast Cancer and Cancer Stem Cells by Inhibiting Long Non-Coding RNAs
Justin M. Brown et al.
CELLS (2020)
circHMCU Promotes Proliferation and Metastasis of Breast Cancer by Sponging the let-7 Family
Xiaojin Song et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Oxidized ATM promotes breast cancer stem cell enrichment through energy metabolism reprogram-mediated acetyl-CoA accumulation
Dan Yang et al.
CELL DEATH & DISEASE (2020)
Targeting cancer stem cell pathways for cancer therapy
Liqun Yang et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1
Dawei Wu et al.
CANCER GENE THERAPY (2019)
Self-renewal signaling pathways in breast cancer stem cells
Lakshmi Vineela Nalla et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2019)
PD-L1 Expression in Human Breast Cancer Stem Cells Is Epigenetically Regulated through Posttranslational Histone Modifications
Pramod Darvin et al.
JOURNAL OF ONCOLOGY (2019)
Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer
Jin-huan Xu et al.
CANCER BIOMARKERS (2019)
Identification of Breast Cancer Stem Cell Related Genes Using Functional Cellular Assays Combined With Single-Cell RNA Sequencing in MDA-MB-231 Cells
Emma Jonasson et al.
FRONTIERS IN GENETICS (2019)
CircAGFG1 sponges miR-203 to promote EMT and metastasis of non-small-cell lung cancer by upregulating ZNF281 expression
Yi-Bo Xue et al.
THORACIC CANCER (2019)
Distinct functions of AKT isoforms in breast cancer: a comprehensive review
Nico Hinz et al.
CELL COMMUNICATION AND SIGNALING (2019)
Unraveling the journey of cancer stem cells from origin to metastasis
Rama Krishna Nimmakayala et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
MicroRNAs and breast cancer stem cells: Potential role in breast cancer therapy
Fatemeh Vahidian et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
A Sox2-Sox9 signalling axis maintains human breast luminal progenitor and breast cancer stem cells
Giacomo Domenici et al.
ONCOGENE (2019)
Poly(ADP-Ribose) Polymerase Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy
Awad Jarrar et al.
STEM CELLS (2019)
Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation
Yan Xing et al.
BREAST CANCER RESEARCH (2019)
LncCCAT1 Promotes Breast Cancer Stem Cell Function through Activating WNT/beta-catenin Signaling
Tingting Tang et al.
THERANOSTICS (2019)
Replication Stress Drives Constitutive Activation of the DNA Damage Response and Radioresistance in Glioblastoma Stem-like Cells
Ross D. Carruthers et al.
CANCER RESEARCH (2018)
MicroRNA Key to Angiogenesis Regulation: miRNA Biology and Therapy
Ankit Tiwari et al.
CURRENT CANCER DRUG TARGETS (2018)
Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+breast cancer cell proliferation and stem cell survival
Andrew Baker et al.
ONCOGENE (2018)
Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance
Sonia Palomeras et al.
MOLECULES (2018)
Breast cancer stem cells: Features, key drivers and treatment options
Juergen Dittmer
SEMINARS IN CANCER BIOLOGY (2018)
The pro-metastasis effect of circANKS1B in breast cancer
Kaixuan Zeng et al.
MOLECULAR CANCER (2018)
NAMPT Is a Potent Oncogene in Colon Cancer Progression that Modulates Cancer Stem Cell Properties and Resistance to Therapy through Sirt1 and PARP
Antonio Lucena-Cacace et al.
CLINICAL CANCER RESEARCH (2018)
Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer
Jason. P. W. Carey et al.
CANCER RESEARCH (2018)
Cancer vaccine strategies: translation from mice to human clinical trials
Jay A. Berzofsky et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)
RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer
Yajing Liu et al.
CLINICAL CANCER RESEARCH (2017)
Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)
Masaru Katoh
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
DNA damage repair in breast cancer and its therapeutic implications
Reem Ali et al.
PATHOLOGY (2017)
Circular RNA profile indicates circular RNA VRK1 is negatively related with breast cancer stem cells
Ningning Yan et al.
ONCOTARGET (2017)
Inhibition of FAK kinase activity preferentially targets cancer stem cells
Vihren N. Kolev et al.
ONCOTARGET (2017)
Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly
Xiaoti Lin et al.
THERANOSTICS (2017)
miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling
Rita El Helou et al.
CELL REPORTS (2017)
TGF-β-Induced Quiescence Mediates Chemoresistance of Tumor-Propagating Cells in Squamous Cell Carcinoma
Jessie A. Brown et al.
CELL STEM CELL (2017)
Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer
Stefania Lanzardo et al.
CANCER RESEARCH (2016)
LncRNA-Hh Strengthen Cancer Stem Cells Generation in Twist-Positive Breast Cancer via Activation of Hedgehog Signaling Pathway
Mingli Zhou et al.
STEM CELLS (2016)
Isocyclopamine, a novel synthetic derivative of cyclopamine, reverts doxorubicin resistance in MCF-7/ADR cells by increasing intracellular doxorubicin accumulation and downregulating breast cancer stem-like cells
Ming Liu et al.
TUMOR BIOLOGY (2016)
The Effect of Treatment Advances on the Mortality Results of Breast Cancer Screening Trials: A Microsimulation Model
Jeanette Birnbaum et al.
ANNALS OF INTERNAL MEDICINE (2016)
Cancer Stem Cells: Basic Concepts and Therapeutic Implications
Dany Nassar et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells
X. Sun et al.
CANCER GENE THERAPY (2016)
Quantitative evaluation of ABC transporter-mediated drug resistance based on the determination of the anticancer activity of camptothecin against breast cancer stem cells using TIRF
Parthasarathy Arumugam et al.
INTEGRATIVE BIOLOGY (2016)
MicroRNA-200c delivered by solid lipid nanoparticles enhances the effect of paclitaxel on breast cancer stem cell
Jingwen Liu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis
Mousumi Majumder et al.
STEM CELLS (2016)
Selective Inhibition of Parallel DNA Damage Response Pathways Optimizes Radiosensitization of Glioblastoma Stem-like Cells
Shafiq U. Ahmed et al.
CANCER RESEARCH (2015)
Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations
Kiera Rycaj et al.
CANCER RESEARCH (2015)
Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
Yongmin Yan et al.
STEM CELLS TRANSLATIONAL MEDICINE (2015)
Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells
M. Venere et al.
CELL DEATH AND DIFFERENTIATION (2014)
MiR-7, Inhibited Indirectly by LincRNA HOTAIR, Directly Inhibits SETDB1 and Reverses the EMT of Breast Cancer Stem Cells by Downregulating the STAT3 Pathway
Hongyi Zhang et al.
STEM CELLS (2014)
Prognostic significance of NANOG and KLF4 for breast cancer
Takuya Nagata et al.
BREAST CANCER (2014)
Targeting of preexisting and induced breast cancer stem cells with trastuzumab and trastuzumab emtansine (T-DM1)
J. Diessner et al.
CELL DEATH & DISEASE (2014)
Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
Suling Liu et al.
STEM CELL REPORTS (2014)
HER2 and Breast Cancer Stem Cells: More than Meets the Eye
Hasan Korkaya et al.
CANCER RESEARCH (2013)
HER2 Drives Luminal Breast Cancer Stem Cells in the Absence of HER2 Amplification: Implications for Efficacy of Adjuvant Trastuzumab
Suthinee Ithimakin et al.
CANCER RESEARCH (2013)
miR-7 Suppresses Brain Metastasis of Breast Cancer Stem-Like Cells By Modulating KLF4
Hiroshi Okuda et al.
CANCER RESEARCH (2013)
Preclinical and Clinical Studies of Gamma Secretase Inhibitors with Docetaxel on Human Breast Tumors
Anne F. Schott et al.
CLINICAL CANCER RESEARCH (2013)
Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress
Surendra Singh et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Preferential expression of cancer/testis genes in cancer stem-like cells: proposal of a novel sub-category, cancer/testis/stem gene
R. Yamada et al.
TISSUE ANTIGENS (2013)
T cells sensitized with breast tumor progenitor cell vaccine have therapeutic activity against spontaneous HER2/neu tumors
Li-Xin Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression
J. M. Houthuijzen et al.
BRITISH JOURNAL OF CANCER (2012)
Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update
Xuyu Zu et al.
CELL AND TISSUE RESEARCH (2012)
MicroRNAs in breast cancer initiation and progression
Huiping Liu
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells
Nadire Duru et al.
CLINICAL CANCER RESEARCH (2012)
Emerging roles of the FBW7 tumour suppressor in stem cell differentiation
Zhiwei Wang et al.
EMBO REPORTS (2012)
The evolving concept of cancer and metastasis stem cells
Irene Baccelli et al.
JOURNAL OF CELL BIOLOGY (2012)
Regulation of KLF4 Turnover Reveals an Unexpected Tissue-Specific Role of pVHL in Tumorigenesis
Armin M. Gamper et al.
MOLECULAR CELL (2012)
ERK1 and ERK2 regulate embryonic stem cell self-renewal through phosphorylation of Klf4
Myoung Ok Kim et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Cytotoxic T-Lymphocyte Associated Antigen 4 Polymorphisms and Asthma Risk: A Meta-Analysis
Wei Nie et al.
PLOS ONE (2012)
Breast Cancer Stem Cell-Like Cells Are More Sensitive to Ionizing Radiation than Non-Stem Cells: Role of ATM
Seog-Young Kim et al.
PLOS ONE (2012)
Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
Austin Gurney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status
Hee Jeong Kim et al.
BREAST (2011)
Regulation of Kruppel-like Factor 4 by the Anaphase Promoting Complex Pathway Is Involved in TGF-β Signaling
Dong Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Targeted therapies for breast cancer
Michaele J. Higgins et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Breast cancer stem cells, cytokine networks, and the tumor microenvironment
Hasan Korkaya et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Heterogeneity in breast cancer
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2011)
Insight into the heterogeneity of breast cancer through next-generation sequencing
Hege G. Russnes et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial
Soyoung Baek et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
The E3 ligase Itch is a negative regulator of the homeostasis and function of hematopoietic stem cells
Chozhavendan Rathinam et al.
NATURE IMMUNOLOGY (2011)
Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion
F. Yu et al.
ONCOGENE (2011)
Breast Cancer Management: Opportunities and Barriers to an Individualized Approach
Edith A. Perez
ONCOLOGIST (2011)
The Phenotypic Radiation Resistance of CD44+/CD24-or low Breast Cancer Cells Is Mediated through the Enhanced Activation of ATM Signaling
Hong Yin et al.
PLOS ONE (2011)
Kruppel-like Factor 4 Inhibits Tumorigenic Progression and Metastasis in a Mouse Model of Breast Cancer
Jennifer L. Yori et al.
NEOPLASIA (2011)
Heterogeneity for Stem Cell-Related Markers According to Tumor Subtype and Histologic Stage in Breast Cancer
So Yeon Park et al.
CLINICAL CANCER RESEARCH (2010)
Targeting breast cancer stem cells
Sean P. McDermott et al.
MOLECULAR ONCOLOGY (2010)
Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells
F. Yu et al.
ONCOGENE (2010)
Senescence evasion by MCF-7 human breast tumor-initiating cells
Feridoun Karimi-Busheri et al.
BREAST CANCER RESEARCH (2010)
CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts
E. Marangoni et al.
BRITISH JOURNAL OF CANCER (2009)
Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature
Emmanuelle Charafe-Jauffret et al.
CANCER RESEARCH (2009)
An Epigenetic Switch Involving NF-κB, Lin28, Let-7 MicroRNA, and IL6 Links Inflammation to Cell Transformation
Dimitrios Iliopoulos et al.
CELL (2009)
Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening
Piyush B. Gupta et al.
CELL (2009)
PTEN, Stem Cells, and Cancer Stem Cells
Reginald Hill et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Integrins in mammary-stem-cell biology and breast-cancer progression - a role in cancer stem cells?
Stephanie M. Pontier et al.
JOURNAL OF CELL SCIENCE (2009)
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Maximilian Diehn et al.
NATURE (2009)
Physiological functions of the HECT family of ubiquitin ligases
Daniela Rotin et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Trastuzumab as adjuvant systemic therapy for HER2-positive breast cancer
Gabriella Mariani et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2009)
Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling
Hasan Korkaya et al.
PLOS BIOLOGY (2009)
A stochastic model for cancer stem cell origin in metastatic colon cancer
Christine Odoux et al.
CANCER RESEARCH (2008)
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function
Suleiman Massarweh et al.
CANCER RESEARCH (2008)
The clinicopathologic and prognostic significance of CD44+/CD24-/low and CD44-/CD24+ tumor cells in invasive breast carcinomas
Eleni Mylona et al.
HUMAN PATHOLOGY (2008)
The mir-200 family and mir-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
Philip A. Gregory et al.
NATURE CELL BIOLOGY (2008)
The role of PTEN signaling perturbations in cancer and in targeted therapy
M. Keniry et al.
ONCOGENE (2008)
HER2 regulates the mammary stem/progenitor cell population driving tumorigenesis and invasion
H. Korkaya et al.
ONCOGENE (2008)
Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer
Helga Bernhard et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Jane E. Visvader et al.
NATURE REVIEWS CANCER (2008)
Breast cancer stem cells: implications for therapy of breast cancer
Brian J. Morrison et al.
BREAST CANCER RESEARCH (2008)
Iet-7 regulates self renewal and tumorigenicity of breast cancer cells
Fengyan Yu et al.
CELL (2007)
IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland
Pasquale Sansone et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Loss of β-catenin impairs the renewal of normal and CML stem cells in vivo
Chen Zhao et al.
CANCER CELL (2007)
Novel cell culture technique for primary ductal carcinoma in situ: Role of notch and epidermal growth factor receptor signaling pathways
Gillian Farnie et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma
Craig D. Peacock et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Molecular definition of breast tumor heterogeneity
Michail Shipitsin et al.
CANCER CELL (2007)
The tumour microenvironment as a target for chemoprevention
Adriana Albini et al.
NATURE REVIEWS CANCER (2007)
Individual stem cells with highly variable proliferation and self-renewal properties comprise the human hematopoietic stem cell compartment
Joby L. McKenzie et al.
NATURE IMMUNOLOGY (2006)
Notch signalling regulates stem cell numbers in vitro and in vivo
Andreas Androutsellis-Theotokis et al.
NATURE (2006)
Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells
Suling Liu et al.
CANCER RESEARCH (2006)
CD44(+)/CD24(-) breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
Carol Sheridan et al.
BREAST CANCER RESEARCH (2006)
Destabilization of Kruppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway
ZY Chen et al.
CANCER RESEARCH (2005)
The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene
BD Rowland et al.
NATURE CELL BIOLOGY (2005)
Effect of screening and adjuvant therapy on mortality from breast cancer
DA Berry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Stem cells in mammary development and carcinogenesis - Implications for prevention and treatment
Gabriela Dontu et al.
STEM CELL REVIEWS (2005)
Self-renewal and solid-tumor stem cells
MF Clarke
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer
AY Pandya et al.
CLINICAL CANCER RESEARCH (2004)
Pheophorbide a is a specific probe for ABCG2 function and inhibition
RW Robey et al.
CANCER RESEARCH (2004)
Self-renewal and solid tumor stem cells
M Al-Hajj et al.
ONCOGENE (2004)
The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome
AR Panigrahi et al.
JOURNAL OF PATHOLOGY (2004)
Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis
S Pece et al.
JOURNAL OF CELL BIOLOGY (2004)
The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation
T Holbro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Update on HER-2 as a target for cancer therapy - Intracellular signaling pathways of ErbB2/HER-2 and family members
MA Olayioye
BREAST CANCER RESEARCH (2001)
Share Paper
